Cumberland Pharmaceuticals
CPIX
27 hedge funds and large institutions have $11.8M invested in Cumberland Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 11 reducing their positions, and 7 closing their positions.
11% more capital invested
Capital invested by funds: $10.6M → $11.8M (+$1.14M)
9% more call options, than puts
Call options by funds: $233K | Put options by funds: $214K
2.99% less ownership
Funds ownership: 22.77% → 19.77% (-3%)
10% less funds holding
Funds holding: 30 → 27 (-3)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
64% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$1.01M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$143K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$77.2K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$43.1K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$16.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$1.87M |
| 2 |
JGC
J. Goldman & Co
New York
|
-$337K |
| 3 |
Renaissance Technologies
New York
|
-$128K |
| 4 |
BFM
Boothbay Fund Management
New York
|
-$117K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$73.8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Bank of America
Charlotte,
North Carolina
| $36 | -$24 | -8 | -47% |
|
|
HNB
27
Huntington National Bank
Columbus,
Ohio
| $4 | – | – | – |
|
|
28
Millennium Management
New York
| – | -$1.87M | -598,634 | Closed |
|
|
XT
29
XTX Topco
George Town,
Cayman Islands
| – | -$33K | -10,591 | Closed |
|
30
Group One Trading
Chicago,
Illinois
| – | -$22.9K | -7,742 | Closed |
|
|
TRCT
31
Tower Research Capital (TRC)
New York
| – | -$2.46K | -787 | Closed |
|
32
Jones Financial Companies
Des Peres,
Missouri
| – | -$1.85K | -600 | Closed |
|
|
FFA
33
Farther Finance Advisors
San Francisco,
California
| – | -$1.08K | -345 | Closed |
|
34
Citigroup
New York
| – | -$12 | -4 | Closed |
|
CPIX Hedge Fund Activity: Q4 2025 in Review
27 of the 8,228 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q4 2025, worth a combined $11.8M — up 11% from $10.6M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of CPIX and 4 opened new positions — a net loss of 3 holders — while 11 trimmed existing stakes and 4 added.
The largest buyer was Perceptive Advisors, opening a new position worth an estimated $1.01M. The largest seller was Millennium Management, exiting entirely with an estimated $1.87M sold.
- 27 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q4 2025, down from 30 in Q3 2025.
- Funds reported $11.8M of Cumberland Pharmaceuticals stock for Q4 2025, up 11% quarter-over-quarter.
- 4 funds opened new Cumberland Pharmaceuticals positions in Q4 2025 and 7 closed out, a net change of -3 holders.
- The largest Cumberland Pharmaceuticals buyer in Q4 2025 was Perceptive Advisors, an estimated $1.01M added.
- The largest Cumberland Pharmaceuticals seller in Q4 2025 was Millennium Management, an estimated $1.87M sold.
Based on aggregated 13F filings for Q4 2025.